Ferner R E, Alberti K G, Rawlins M D
Hum Toxicol. 1986 Jul;5(4):283-4. doi: 10.1177/096032718600500413.
A 49-year-old man with non-insulin-dependent diabetes mellitus (NIDDM) from alcoholic pancreatitis took 100 mg of glibenclamide without symptoms of hypoglycaemia even when glibenclamide concentrations were high (191 micrograms/l). There was no increase in serum C-peptide concentration. The observed half-life of glibenclamide was 6 h. It is concluded that high doses of glibenclamide will not provoke pancreatic insulin secretion in NIDDM caused by pancreatic destruction, there was no evidence for an acute extra-pancreatic effect of glibenclamide and the elimination of glibenclamide may be slower than supposed previously.
一名49岁因酒精性胰腺炎导致非胰岛素依赖型糖尿病(NIDDM)的男子,服用100毫克格列本脲后未出现低血糖症状,即便格列本脲浓度很高(191微克/升)。血清C肽浓度也未升高。观察到的格列本脲半衰期为6小时。结论是,高剂量格列本脲不会刺激因胰腺破坏导致的NIDDM患者的胰腺胰岛素分泌,没有证据表明格列本脲有急性胰腺外效应,且格列本脲的消除可能比之前认为的要慢。